An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Latest Information Update: 04 Sep 2019
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacokinetics; Registrational
- Acronyms FUTURE-1
- Sponsors Actelion Pharmaceuticals
Most Recent Events
- 05 Aug 2019 New trial record